|
1
|
Tran L, Xiao JF, Agarwal N, Duex JE and
Theodorescu D: Advances in bladder cancer biology and therapy. Nat
Rev Cancer. 21:104–121. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Richters A, Aben KKH and Kiemeney LALM:
The global burden of urinary bladder cancer: An update. World J
Urol. 38:1895–1904. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel VG, Oh WK and Galsky MD: Treatment
of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J
Clin. 70:404–423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lenis AT, Lec PM, Chamie K and Mshs MD:
Bladder cancer: A review. JAMA. 324:1980–1991. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fus ŁP and Górnicka B: Role of
angiogenesis in urothelial bladder carcinoma. Cent European J Urol.
69:258–263. 2016.PubMed/NCBI
|
|
6
|
Sonpavde G and Bellmunt J: Bladder cancer:
Angiogenesis as a therapeutic target in urothelial carcinoma. Nat
Rev Urol. 13:306–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wigner P, Grębowski R, Bijak M,
Saluk-Bijak J and Szemraj J: The interplay between oxidative
stress, inflammation and angiogenesis in bladder cancer
development. Int J Mol Sci. 22:44832021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang K, Liu D, Zhao J, Shi S, He X, Da P,
You Y and You B: Nuclear exosome HMGB3 secreted by nasopharyngeal
carcinoma cells promotes tumour metastasis by inducing
angiogenesis. Cell Death Dis. 12:5542021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goodall GJ and Wickramasinghe VO: RNA in
cancer. Nat Rev Cancer. 21:22–36. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan H and Bu P: Non-coding RNA in cancer.
Essays Biochem. 65:625–639. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Li G, Guo X, Yao H, Wang G and Li C:
Non-coding RNA in bladder cancer. Cancer Lett. 485:38–44. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
et al: Bladder cancer: Epidemiology, staging and grading, and
diagnosis. Urology. 66 (6 Suppl 1):S4–S34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang G and McKenney JK: Urinary bladder
pathology: World Health Organization classification and American
joint committee on cancer staging update. Arch Pathol Lab Med.
143:571–577. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Witjes JA, Bruins HM, Cathomas R, Compérat
EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A,
Neuzillet Y, et al: European association of urology guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2020
guidelines. Eur Urol. 79:82–104. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao S, Yin H, Tong H, Zhan K, Yang G,
Hossain MA, Li T, Gou X and He W: Nucleolar and spindle associated
protein 1 (NUSAP1) promotes bladder cancer progression through the
TGF-β signaling pathway. Onco Targets Ther. 13:813–825. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan X, Jiang M, Deng W, Liu X, Chen L and
Fu B: Development and validation of a prognostic nomogram for
predicting cancer-specific survival in patients with lymph node
positive bladder cancer: A study based on SEER database. Front
Oncol. 12:7890282022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao Z, Zhao K, Jose I, Hoogenraad NJ and
Osellame LD: Biomarkers for cancer cachexia: A mini review. Int J
Mol Sci. 22:45012021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel SP and Kurzrock R: PD-L1 expression
as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther.
14:847–856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Zhao X, Jiang XL, Lu D, Yuan Q and
Li J: Diagnostic performance of nuclear matrix protein 22 and urine
cytology for bladder cancer: A meta-analysis. Diagn Cytopathol.
50:300–312. 2022. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Shu K, Zhou J, Yu Q, Cui S, Liu J,
Zhou R and Ding D: Preoperative plasma fibrinogen and D-dimer as
prognostic biomarkers for non-muscle-invasive bladder cancer. Clin
Genitourin Cancer. 18:11–19. e12020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan TC, Hsing CH, Shiue YL, Huang SK,
Hsieh KL, Kuo YH and Li CF: Angiogenesis driven by the
CEBPD-hsa-miR-429-VEGFA signaling axis promotes urothelial
carcinoma progression. Cells. 11:6382022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Viallard C and Larrivée B: Tumor
angiogenesis and vascular normalization: Alternative therapeutic
targets. Angiogenesis. 20:409–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oguntade AS, Al-Amodi F, Alrumayh A,
Alobaida M and Bwalya M: Anti-angiogenesis in cancer therapeutics:
The magic bullet. J Egypt Natl Canc Inst. 33:152021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hariprabu KNG, Sathya M and Vimalraj S:
CRISPR/Cas9 in cancer therapy: A review with a special focus on
tumor angiogenesis. Int J Biol Macromol. 192:913–930. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armani G, Pozzi E, Pagani A, Porta C,
Rizzo M, Cicognini D, Rovati B, Moccia F, Pedrazzoli P and Ferraris
E: The heterogeneity of cancer endothelium: The relevance of
angiogenesis and endothelial progenitor cells in cancer
microenvironment. Microvasc Res. 138:1041892021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vallée A, Guillevin R and Vallée JN:
Vasculogenesis and angiogenesis initiation under normoxic
conditions through Wnt/β-catenin pathway in gliomas. Rev Neurosci.
29:71–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaaf MB, Houbaert D, Meçe O and
Agostinis P: Autophagy in endothelial cells and tumor angiogenesis.
Cell Death Differ. 26:665–679. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu
H, Zhong G, Li Y, Li J, Huang J, et al: Exosomal long noncoding RNA
LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin
Invest. 130:404–421. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng R, Du M, Wang X, Xu W, Liang J, Wang
W, Lv Q, Qin C, Chu H, Wang M, et al: Exosome-transmitted long
non-coding RNA PTENP1 suppresses bladder cancer progression. Mol
Cancer. 17:1432018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Zhang C, Peng X, Li Y, Chen G, Gou
X, Zhou X and Ma C: A novel risk score model based on five
angiogenesis-related long non-coding RNAs for bladder urothelial
carcinoma. Cancer Cell Int. 22:1572022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tong H, Li T, Gao S, Yin H, Cao H and He
W: An epithelial-mesenchymal transition-related long noncoding RNA
signature correlates with the prognosis and progression in patients
with bladder cancer. Biosci Rep. 41:BSR202039442021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qing L, Gu P, Liu M, Shen J, Liu X, Guang
R, Ke K, Huang Z, Lee W and Zhao H: Extracellular matrix-related
six-lncRNA signature as a novel prognostic biomarker for bladder
cancer. Onco Targets Ther. 13:12521–12538. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Claesson-Welsh L and Welsh M: VEGFA and
tumour angiogenesis. J Intern Med. 273:114–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J,
Zhou Z, Zhang W, Qin L and Huang G: LncRNA PVT1 promotes
angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Oncogene. 37:4094–4109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu R, Bi R, Jiang L, Yang X, Zhong Y and
Xie X: LncRNA TUSC8 suppresses the proliferation and migration of
esophageal cancer cells by downregulation of VEGFA. J Cancer.
12:6393–6400. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo H, Li J, Fan F and Zhou P: LINC00707
regulates miR-382-5p/VEGFA pathway to enhance cervical cancer
progression. J Immunol Res. 2021:55246322021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen L, Qiu CH, Chen Y, Wang Y, Zhao JJ
and Zhang M: LncRNA SNHG16 drives proliferation, migration, and
invasion of lung cancer cell through modulation of miR-520/VEGF
axis. Eur Rev Med Pharmacol Sci. 24:9522–9531. 2020.PubMed/NCBI
|
|
39
|
Cao W, Zhao Y, Wang L and Huang X:
Circ0001429 regulates progression of bladder cancer through binding
miR-205-5p and promoting VEGFA expression. Cancer Biomark.
25:101–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang H, Niu X, Jiang H, Mao F, Zhong B,
Jiang X and Fu G: Long non-coding RNA DLX6-AS1 facilitates bladder
cancer progression through modulating miR-195-5p/VEGFA signaling
pathway. Aging (Albany NY). 12:16021–16034. 2020. View Article : Google Scholar : PubMed/NCBI
|
